advertisement
Gida Covid-19

Covid-19

Rukunin COVID-19 na Kimiyya na Turai
Halayen: Gidan Hoton NIH daga Bethesda, Maryland, Amurka, yankin Jama'a, ta hanyar Wikimedia Commons
Wata sabuwar hanyar sadarwa ta duniya na dakunan gwaje-gwaje don coronaviruses, CoViNet, WHO ta ƙaddamar da shi. Manufar da ke bayan wannan yunƙurin ita ce haɗa shirye-shiryen sa ido da dakunan gwaje-gwaje don tallafawa ingantaccen sa ido kan cututtukan cututtuka da kima (phenotypic and genotypic) ...
An san cewa COVID-19 yana ƙara haɗarin bugun zuciya, bugun jini, da Dogon COVID amma abin da ba a sani ba shine ko lalacewar ta faru ne saboda kwayar cutar tana cutar da ƙwayar zuciya da kanta, ko kuma saboda kumburin tsarin da aka fara…
Bambancin JN.1 wanda samfurin farko da aka rubuta a ranar 25 ga Agusta 2023 wanda daga baya masu binciken suka ba da rahoton cewa yana da mafi girman watsawa da ikon tserewa, yanzu WHO ta ayyana bambance-bambancen sha'awa (VOIs). A cikin ƴan kwanakin nan...
Maye gurbi (S: L455S) shine babban maye gurbi na JN.1 wanda ke daɗa haɓaka ƙarfin gujewa na rigakafi wanda ke ba shi damar gujewa kamuwa da ƙwayoyin cuta na Class 1 yadda ya kamata. Wani bincike yana goyan bayan amfani da sabbin alluran rigakafin COVID-19 tare da furotin mai kauri don ƙara…
Abin mamaki ne dalilin da ya sa kasar Sin ta zabi daukar matakin sifiri-COVID tare da kawar da tsauraran matakan NPI, a cikin hunturu, kafin sabuwar shekara ta Sinawa, lokacin da BF.7 mai saurin yaduwa ya riga ya fara yawo. "WHO ya damu sosai da ...
Spikevax Bivalent Original/Omicron Booster Vaccine, farkon bivalent COVID-19 mai haɓaka rigakafin da Moderna ya haɓaka ya sami amincewar MHRA. Ba kamar na asali na Spikevax ba, sigar bivalent ta yi niyya ga bambance-bambancen coronavirus na asali daga 2020 da bambance-bambancen Omicron da ...
Coronaviruses da ƙwayoyin cuta na mura suna kula da acidity na aerosol. Matsakaicin pH cikin gaggawa na coronaviruses yana yiwuwa ta hanyar wadatar da iska ta cikin gida tare da matakan nitric acid marasa haɗari. Akasin haka, matatar iska ta cikin gida na iya cire acid ɗin da ba ta da kyau ba da gangan ba don haka ya tsawaita...
An riga an ba da rahoto game da cututtukan haɗin gwiwa tare da bambance-bambancen guda biyu. Ba a san da yawa ba game da sake haɗewar ƙwayar cuta da ke haifar da ƙwayoyin cuta tare da kwayoyin halitta. Nazari biyu na baya-bayan nan sun ba da rahoton shari'o'in sake hadewar kwayoyin halitta a tsakanin bambance-bambancen SARS-CoV-2 Denta & Omicron. Recombinant, mai suna Deltamicron, ya...
WHO ta sabunta ka'idodinta na rayuwa game da maganin COVID-19. Sabuntawa na tara da aka fitar akan 03 Maris 2022 sun haɗa da shawarwarin sharadi akan molnupiravir. Molnupiravir ya zama maganin rigakafi na baka na farko da aka haɗa cikin jagororin jiyya na COVID-19.
Omicron BA.2 subvariant alama ya zama mafi watsawa fiye da BA.1. Hakanan yana da kaddarorin rigakafin rigakafi waɗanda ke ƙara rage tasirin rigakafin rigakafin kamuwa da cuta. A ranar 26 ga Nuwamba, 2021, WHO ta ayyana B.1.1.529 bambance-bambancen na SARS-CoV-2 a matsayin Bambancin ...
NeoCoV, nau'in coronavirus da ke da alaƙa da MERS-CoV da aka samu a cikin jemagu (NeoCoV ba sabon bambance-bambancen SARS-CoV-2 bane, nau'in coronavirus ɗan adam da ke da alhakin cutar ta COVID-19) an ba da rahoton zama shari'ar farko ta MERS- Bambancin CoV ta amfani da ACE2 ....
Neman rigakafin COVID-19 na duniya, mai tasiri ga duk bambance-bambancen coronaviruses na yanzu da na gaba abu ne mai mahimmanci. Manufar ita ce a mai da hankali kan yankin da ba a iya canzawa ba, wanda aka fi kiyayewa daga cutar, maimakon yankin da ke canzawa akai-akai.
Gwamnati a Ingila kwanan nan ta ba da sanarwar ɗaga matakan shirin B a cikin lamuran Covid-19 da ke ci gaba, wanda ke sa sanya abin rufe fuska ba dole ba, barin aiki daga gida kuma ba bu wata doka ta nuna dokar rigakafin COVID-XNUMX don halartar…
Daga ranar 27 ga Janairu, 2022, ba zai zama tilas a sanya abin rufe fuska ba ko buƙatar nuna izinin wucewa na COVID a Ingila. Matakan da aka sanya a karkashin shirin B na Ingila, da za a dage su. Tun a ranar 8 ga Disamba...
Bambancin jinsin OAS1 an sanya shi cikin rage haɗarin cutar COVID-19 mai tsanani. Wannan yana ba da garantin wakilai / magunguna masu haɓaka waɗanda zasu iya haɓaka matakin OAS1 enzyme, ta haka rage tsananin COVID-19. An san tsofaffin shekaru da cututtuka ...
An fito da sigar takwas (sabuntawa ta bakwai) na jagorar rayuwa. Yana maye gurbin sigar farko. Sabbin sabuntawa sun haɗa da ƙaƙƙarfan shawarwari don amfani da baricitinib a matsayin madadin interleukin-6 (IL-6), shawarwarin sharadi don amfani da ...
Deltacron ba sabon iri bane ko bambance-bambancen amma yanayin kamuwa da cuta tare da bambance-bambancen guda biyu na SARS-CoV-2. A cikin shekaru biyu da suka gabata, bambance-bambancen daban-daban sun fito daga nau'in SARS CoV-2 tare da nau'ikan kamuwa da cuta da…
Wani sabon bambance-bambancen da ake kira 'IHU' (sabon zuriyar Pangolin mai suna B.1.640.2) an ruwaito ya bayyana a kudu maso gabashin Faransa. Masu bincike a Marseille, Faransa sun ba da rahoton gano wani sabon salo na coronavirus SARS-CoV-2. Mai haƙuri yana da tarihin balaguron kwanan nan...
Bayan kimantawa da amincewa da Hukumar Kula da Magunguna ta Turai (EMA), WHO ta fitar da jerin abubuwan amfani da gaggawa (EUL) don Nuvaxovid a ranar 21 ga Disamba 2021. Tun da farko a ranar 17 ga Disamba 2021, WHO ta ba da lissafin amfani da gaggawa (EUL) don Covovax. Covovax da Nuvaxoid don haka sun zama ...
Shaidu ya zuwa yanzu suna ba da shawarar cewa Omicron bambance-bambancen na SARS-CoV-2 yana da ƙimar watsawa mai yawa amma an yi sa'a yana da ƙarancin kamuwa da cuta kuma yawanci ba ya haifar da mummunan alamun cutar COVID-19 ko mace-mace. Amma da alama alluran rigakafin da ake da su sun yi ƙasa da ƙasa...
Kashi ɗaya na maganin na iya ƙara ɗaukar allurar cikin sauri wanda ya zama wajibi a ƙasashe da yawa inda matakin ɗaukar allurar ba shi da kyau. WHO ta sabunta shawarwarinta na wucin gadi1 game da amfani da Janssen Ad26.COV2.S (COVID-19). Jadawalin kashi daya na...
Sotrovimab, riga-kafi da aka riga aka amince da shi don COVID-19 mai sauƙi zuwa matsakaici a cikin ƙasashe da yawa ya sami amincewa daga MHRA a Burtaniya. An ƙera wannan rigakafin da hankali tare da ƙwayar cuta mai canzawa a zuciya. Yankin da aka kiyaye sosai na furotin mai karu shine...
adenoviruses guda uku da aka yi amfani da su azaman vectors don samar da rigakafin COVID-19, suna ɗaure zuwa nau'in platelet 4 (PF4), furotin da ke da alaƙa a cikin cututtukan cututtukan jini. Abubuwan da ake amfani da su na Adenovirus COVID-19 irin su Oxford/AstraZeneca's ChAdOx1 suna amfani da yanayin sanyi mai rauni kuma wanda aka canza ta asali.
Ɗayan sabon abu mai ban sha'awa kuma mafi ban sha'awa na bambance-bambancen Omicron wanda ya rikiɗe shi ne cewa ya sami duk maye gurbi a fashe guda ɗaya cikin ɗan gajeren lokaci. Matsayin canjin yana da yawa don haka wasu ...
Don haɓaka matakan kariya a cikin yawan jama'a game da bambancin Omicron, Kwamitin Haɗin gwiwa kan Alurar riga kafi da rigakafi (JCVI)1 na Burtaniya ya ba da shawarar cewa ya kamata a faɗaɗa shirin ƙarfafawa don haɗa duk sauran manya masu shekaru 18 ...

Biyo mu ta kafofin Sada Zumunta

92,810FansKamar
47,297FollowersFollow
1,772FollowersFollow
43biyan kuɗiLabarai
- Labari -

SAURARAWA